Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

COLINZ LABORATORIES LTD.

Healthcare › Pharmaceuticals & Biotechnology
₹69.00
at close · 27 Oct 2026
▲ 1.55 (+2.30%)

Latest filings

Next results: Thu, 29 Oct · Financial Results
  1. Board Meeting on Oct 29, 2026 to Approve Q2/Half-Year Results · Results
  2. Routine compliance certificate under SEBI Regulation 74(5) for Sep 2026 quarter · Compliance
  3. Reg 32 non-applicability declaration for Q2 FY27 · Compliance
All filings ↓
Ask Nexa about COLINZ LABORATORIES LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹6 Cr over the trailing twelve months.

Market Cap
₹17 Cr
P / E (TTM)
6.2×
EV / EBITDA
4.7×
Div Yield
—
Growth
-0.1%▼
Revenue 5y CAGR
PAT +19.9% · EBITDA +11.3%
Quality
7.3%·
ROCE (5y median)
ROE 5.2% (5y median) · margin 14.5%
Leverage
0.04·
Debt / Equity · low
Net cash ₹0.31 Cr
Revenue FY21→FY26
1.0×▼
Margin +5.0 pts
₹6 Cr → ₹6 Cr
Cash conversion
1.30×▲
Operating cash ÷ profit · 5 yrs
₹3 Cr on ₹2 Cr
Moves on a normal day
3.41%·
Median daily move
Last 266 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#8/158
P/B#47/163
ROCE#117/183
ROE#116/166
Debt / Equity#59/166
EBITDA margin#1/165
Revenue growth#141/161
Profit growth#5/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Profit compounding 20% a year over 5 years
Profit grew in every one of the last 5 years
Debt at 0.04× equity
lower than 65% of its 166 Pharmaceuticals peers
Over 5 years it reported ₹2.29 Cr of profit and ₹2.99 Cr of operating cash — 1.30×
Profit is converting into cash
Concerns
Revenue shrinking over 5 years (0% a year)
Returns on capital 7.3% (5-year median)
#117 of 183 in Pharmaceuticals on the latest reported figures · up from 4.4% in FY21

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from COLINZ LABORATORIES LTD.'s filed financials and exchange disclosures

What does COLINZ LABORATORIES LTD. do?

COLINZ LABORATORIES LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.

Is COLINZ LABORATORIES LTD. profitable?

Yes. Over the trailing twelve months COLINZ LABORATORIES LTD. reported a net profit of ₹2.80 Cr on revenue of ₹5.81 Cr.

Does COLINZ LABORATORIES LTD. pay a dividend?

Not in the latest reported year — COLINZ LABORATORIES LTD.'s dividend payout for FY26 was nil.

Is COLINZ LABORATORIES LTD. debt-free?

On a net basis, yes. It reported borrowings of ₹0.39 Cr on its 31 Mar 2026 balance sheet, but holds ₹0.31 Cr more cash than debt.

Is COLINZ LABORATORIES LTD. expensive compared with its peers?

On trailing P/E, COLINZ LABORATORIES LTD. ranks 8 of 158 in Pharmaceuticals — cheaper than 96% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.

How much does the COLINZ LABORATORIES LTD. share price move in a day?

On a typical session COLINZ LABORATORIES LTD. moves 3.41% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.

When are COLINZ LABORATORIES LTD.'s next results?

Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track COLINZ LABORATORIES LTD.'s announcements?

Every NSE and BSE filing by COLINZ LABORATORIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.